Abstract:The telomere-associated protein tankyrase is a poly(adenosine diphosphate-ribose) polymerase and is considered to be a promising target for cancer therapy, especially selective lethality on breast cancer associated (BRCA) cell lines, including breast cancer as well as malignancies of the ovaries, pancreas, and prostate gland. A variety of drug candidates have been developed and investigated, such as XAV-939, which was identified as a tankyrase inhibitor during screening for a small-molecule inhibitor of the Wnt/beta-catenin pathway, and it exhibits nanomolar activity in the tankyrase-2 biochemical assay. Coincidentally, almost all compounds which exhibit excellent activity in the tankyrase-2 biochemical assay showed the common structure: lactam ring or amide structure. According to the reported co-crystal structure of inhibitors with tankyrase-2 analysis, it was found that the lactam ring or amide of the compounds forms three conserved hydrogen bonds to Gly1032 and Ser1068 and a p-stacking interaction with Tyr1071. Thus the lactam ring or amide was identified to be a key structure of tankyrase inhibitors. So a new class of structure based on benzo[f][1,4] oxazepinone scaffold was designed through computer-aided virtual drug screening, and 12 new compounds were synthesized via Mannich reactions of aromatic aldehydes with aromatic amines and aromatic ketones, ring expansion, reduction and condensation. The target compound was confirmed by H-1 NMR, C-13 NMR, HRMS. Followed by the methyl thiazolyl tetrazolium (MTT) assay to test in vitro anti-tumor activity, part compounds showed potent inhibitory effect on tumor cells. This study culminates in compound 3h, an inhibitor with potent activity against Hep-3B (IC50 = 3.5 mu mol/L). Here, the synthesis and structure-activity relationship (SAR) of this novel series were described. To explore the anti-tumor mechanism of benzo[f][1,4] oxazepinone compounds, we explored the interaction of the compound 3h complex with the Gly1032, Ser1068 and Tyr1071 binding site of tankyrase-2, which confirms the three conserved hydrogen and p-stacking binding mode, as supporting information for the in vitro anti-tumor activity.

Synthesis, Crystal Structure, Anti-Bone Cancer Activity and Molecular Docking Investigations of the Heterocyclic Compound 1-((2S,3S)-2-(Benzyloxy)Pentan-3-yl) -4-(4-(4-(4-Hydroxyphenyl)Piperazin-1-yl) Phenyl)-1H-1,2,4-Triazol-5(4H)-One

Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl) phenyl)-1H-1,2,4-triazol-5(4H)-one

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis, Crystal Structure and Bioactivity of 1-(3-((benzo [D] [1,3] Dioxol-5-Yloxy)Methyl)Phenethyl)-4-Phenylpiperidin-4-Ol

Synthesis,Crystal Structure and Anti-tumor Activity of 2-（2-Chloro-4-nitrophenyl）-4-（4-chlorophenyl）-3a,4-diethoxy-2,3,3a,4-tetrahydrochromeno[3,4-d][1,2,3]diazaphosphole

Synthesis, crystal structure, DFT, molecular docking and antitumor activity of 4-(2-chlorobenzyl)-1-(5-fluoro-2-hydroxy-3-((4-methylpiperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one

Structural Analysis of (S)-1-((1h-benzo[d][1,2,3]triazol-1-yl)oxy)-3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-2-ol and Binding Mechanism with Α1a-Adrenoceptor: TDDFT Calculations, X-ray Crystallography and Molecular Docking

Synthesis and Crystal Structures of Arylpiperazine Compounds (“synthesis Crystal Structures Arylpiperazine” for Short)

Synthesis, Crystal Structure and Antitumor Activity of (E)-1-(7-Methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(2-methoxyphenyl)-2-(1H-1,2,4-triazol-1-yl)propenol

Synthesis, Structural Investigations, DNA/BSA Interactions, Molecular Docking Studies, and Anticancer Activity of a New 1,4-Disubstituted 1,2,3-Triazole Derivative

Synthesis, Structure And Biological Activity Of 2,2-Dimethyl-5-(Substituted Phenyl)-3-(1,2,4-Triazol-1/4-Ylmethyl)Pentan-3-Ol

Synthesis, Crystal Structure, DFT Studies, Hirshfeld Suface Analysis and Antitumor Activity of 4-(tert-Butyl)-5-(1,2,4-triazole-1-yl)thiazole Derivatives Containing Benzoxazinone

Design, Synthesis, Crystal Structure and Antitumor Activity of A New Ethyl 3-(Quinazolin-4-ylamino)-1h-pyrrole-2-carboxylate Derivative

Novel Penta-1,4-Diene-3-One Derivatives Containing Quinazoline And Oxime Ether Fragments: Design, Synthesis And Bioactivity

Design, Combinatorial Synthesis and Biological Evaluations of Novel 3-Amino-1'-((1-aryl-1h-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] Pyrano[2,3-C]phenazine-1,3'-indoline]-2-carbonitrile Antitumor Hybrid Molecules.

Synthesis and Anticancer Activity Evaluation of Benzo[F][1,4] Oxazepinone Derivatives

Crystal Structures and Anticancer Activities of Five Novel Pyrazolone-Enamine Transition Metal Complexes with 4-Benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one

Synthesis, Crystal Structure, DFT Calculation, Hirshfeld Suface Analysis and Antitumor Activity of 4-(Tert-butyl)-5-(1h-1,2,4-triazole-1-yl)thiazole Derivatives Containing Benzoxazinone

Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.

Design, Synthesis, and Antitumor Activity of (E,Z)-1-(dihydrobenzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)-2-propen-1-ones.

Synthesis, anticancer evaluation, preliminary mechanism study of novel 1, 2, 3-triazole-piperlongumine derivatives